Frontiers in Pediatrics (Sep 2022)
Changes in the incidence of acute bacterial meningitis caused by Streptococcus pneumoniae and the implications of serotype replacement in children in Colombia after mass vaccination with PCV10
- Juan David Farfán-Albarracín,
- Juan David Farfán-Albarracín,
- Juan David Farfán-Albarracín,
- Germán Camacho-Moreno,
- Germán Camacho-Moreno,
- Germán Camacho-Moreno,
- Germán Camacho-Moreno,
- Aura Lucia Leal,
- Aura Lucia Leal,
- Aura Lucia Leal,
- Jaime Patiño,
- Jaime Patiño,
- Wilfrido Coronell,
- Wilfrido Coronell,
- Iván Felipe Gutiérrez,
- Iván Felipe Gutiérrez,
- Iván Felipe Gutiérrez,
- Sandra Beltrán,
- Sandra Beltrán,
- Martha I. Álvarez-Olmos,
- Martha I. Álvarez-Olmos,
- Martha I. Álvarez-Olmos,
- Cristina Mariño,
- Cristina Mariño,
- Rocio Barrero,
- Rocio Barrero,
- Rocio Barrero,
- Juan Pablo Rojas,
- Juan Pablo Rojas,
- Juan Pablo Rojas,
- Juan Pablo Rojas,
- Fabio Espinosa,
- Fabio Espinosa,
- Catalina Arango-Ferreira,
- Catalina Arango-Ferreira,
- Catalina Arango-Ferreira,
- Maria Alejandra Suarez,
- Maria Alejandra Suarez,
- Monica Trujillo,
- Monica Trujillo,
- Eduardo López-Medina,
- Eduardo López-Medina,
- Pio López,
- Pio López,
- Hernando Pinzón,
- Hernando Pinzón,
- Nicolás Ramos,
- Nicolás Ramos,
- Vivian Marcela Moreno,
- Anita Montañez
Affiliations
- Juan David Farfán-Albarracín
- Red Neumocolombia, Bogotá, Colombia
- Juan David Farfán-Albarracín
- Departamento de Pediatría, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia
- Juan David Farfán-Albarracín
- HOMI-Fundación Hospital Pediátrico La Misericordia, Bogotá, Colombia
- Germán Camacho-Moreno
- Red Neumocolombia, Bogotá, Colombia
- Germán Camacho-Moreno
- Departamento de Pediatría, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia
- Germán Camacho-Moreno
- HOMI-Fundación Hospital Pediátrico La Misericordia, Bogotá, Colombia
- Germán Camacho-Moreno
- Hospital Infantil Universitario de San José, Bogotá, Colombia
- Aura Lucia Leal
- Red Neumocolombia, Bogotá, Colombia
- Aura Lucia Leal
- Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia
- Aura Lucia Leal
- Grupo para el Control de la Resistencia Bacteriana en Bogotá (GREBO), Bogotá, Colombia
- Jaime Patiño
- Red Neumocolombia, Bogotá, Colombia
- Jaime Patiño
- Fundación Valle de Lili, Cali, Colombia
- Wilfrido Coronell
- Red Neumocolombia, Bogotá, Colombia
- Wilfrido Coronell
- Hospital Infantil Napoleón Franco Pareja, Cartagena, Colombia
- Iván Felipe Gutiérrez
- Red Neumocolombia, Bogotá, Colombia
- Iván Felipe Gutiérrez
- Clínica Infantil Colsubsidio, Bogotá, Colombia
- Iván Felipe Gutiérrez
- 0Clínica Infantil Santa María del Lago-Colsánitas, Bogotá, Colombia
- Sandra Beltrán
- Red Neumocolombia, Bogotá, Colombia
- Sandra Beltrán
- 1Clínica Universitaria Colombia-Clínica Pediátrica Colsanitas, Bogotá, Colombia
- Martha I. Álvarez-Olmos
- Red Neumocolombia, Bogotá, Colombia
- Martha I. Álvarez-Olmos
- Grupo para el Control de la Resistencia Bacteriana en Bogotá (GREBO), Bogotá, Colombia
- Martha I. Álvarez-Olmos
- 2Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia
- Cristina Mariño
- Red Neumocolombia, Bogotá, Colombia
- Cristina Mariño
- 3Hospital Militar Central, Bogotá, Colombia
- Rocio Barrero
- Red Neumocolombia, Bogotá, Colombia
- Rocio Barrero
- 4Hospital Universitario Clínica San Rafael, Bogotá, Colombia
- Rocio Barrero
- 5Unidad de Servicios de Salud Santa Clara, Subred Centro Oriente, Bogotá, Colombia
- Juan Pablo Rojas
- Red Neumocolombia, Bogotá, Colombia
- Juan Pablo Rojas
- 6Fundación Clínica Infantil Club Noel, Cali, Colombia
- Juan Pablo Rojas
- 7Facultad de Ciencias de la Salud, Universidad Libre Seccional Cali, Cali, Colombia
- Juan Pablo Rojas
- 8Facultad de Salud, Universidad del Valle, Cali, Colombia
- Fabio Espinosa
- Red Neumocolombia, Bogotá, Colombia
- Fabio Espinosa
- Hospital Infantil Universitario de San José, Bogotá, Colombia
- Catalina Arango-Ferreira
- Red Neumocolombia, Bogotá, Colombia
- Catalina Arango-Ferreira
- 9Hospital Universitario San Vicente Fundación, Medellín, Colombia
- Catalina Arango-Ferreira
- 0Departamento de Pediatría, Facultad de Medicina, Universidad de Antioquia, Medellin, Colombia
- Maria Alejandra Suarez
- Red Neumocolombia, Bogotá, Colombia
- Maria Alejandra Suarez
- 1Unidad de Servicio de Salud Tunal, Bogotá, Colombia
- Monica Trujillo
- Red Neumocolombia, Bogotá, Colombia
- Monica Trujillo
- 2Hospital Pablo Tobón Uribe, Medellín, Colombia
- Eduardo López-Medina
- Red Neumocolombia, Bogotá, Colombia
- Eduardo López-Medina
- 3Centro Médico Imbanaco, Cali, Colombia
- Pio López
- Red Neumocolombia, Bogotá, Colombia
- Pio López
- 4Hospital Universitario del Valle, Cali, Colombia
- Hernando Pinzón
- Red Neumocolombia, Bogotá, Colombia
- Hernando Pinzón
- Hospital Infantil Napoleón Franco Pareja, Cartagena, Colombia
- Nicolás Ramos
- Red Neumocolombia, Bogotá, Colombia
- Nicolás Ramos
- 5Los COBOS Medical Center, Bogotá, Colombia
- Vivian Marcela Moreno
- Red Neumocolombia, Bogotá, Colombia
- Anita Montañez
- Red Neumocolombia, Bogotá, Colombia
- DOI
- https://doi.org/10.3389/fped.2022.1006887
- Journal volume & issue
-
Vol. 10
Abstract
IntroductionAcute bacterial meningitis (ABM) is a public health problem. The disease has reemerged after the introduction of pneumococcal conjugate vaccines (PCVs) due to an increase in serotypes that are not covered. The objective was to determine the changes in the disease incidence before and after the introduction of the 10-valent vaccine (PCV10) in Colombia.MethodsThis multicenter study was conducted in 17 hospitals in Colombia. Data were collected from January 2008 to December 2019 in 10 hospitals in Bogotá and from January 2017 to December 2019 in seven hospitals in Cali, Medellín and Cartagena. The data were grouped into three periods: 2008–2011, 2012–2015, and 2016-2019.ResultsOf the 706 cases of invasive pneumococcal disease, 81 (11.4%) corresponded to meningitis. The relative incidence in Bogotá in the first period was 0.6 per 100,000 patients ≤ 5 years, decreased to 0.4 per 100,000 patients ≤ 5 years in the second period and increased in the third period to 0.7 per 100,000 patients ≤ 5 years. Serotypes covered by PCV10 decreased from 75 to 9.1%, with Spn19A (31.8%) and Spn34 (13.6%) emerging in the third period. Increased resistance to penicillin (13 to 37%) and to ceftriaxone (5.9 to 16%) was due to the emergence of multidrug-resistant Spn19A. The total mortality rate was 23.5% and increased from 12 to 33%.ConclusionsABM due to pneumococcus has high morbidity and mortality rates. Reemergence of the disease has been observed due to the inclusion of polymerase chain reaction (PCR) for diagnosis and replacement of circulating serotypes after the introduction of PCV10, with an increase in Spn19A, which causes death and exhibits antimicrobial resistance. Continued surveillance is needed.
Keywords